Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
MOMA Therapeutics
Eli Lilly and Company
AstraZeneca
Beijing Biotech
Parabilis Medicines, Inc.
Revolution Medicines, Inc.
Eikon Therapeutics
USWM, LLC (dba US WorldMeds)
Conjupro Biotherapeutics, Inc.
Incyclix Bio
Eli Lilly and Company
GlaxoSmithKline
Orano Med LLC
Artios Pharma Ltd
GI Innovation, Inc.
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Alterome Therapeutics, Inc.
ViroMissile, Inc.
Ascendis Pharma A/S
Pfizer
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
NiKang Therapeutics, Inc.
Revolution Medicines, Inc.
MacroGenics
DualityBio Inc.
Solve Therapeutics
Second Life Therapeutics
Ocellaris Pharma, Inc.
Lipomedix Pharmaceuticals Inc.
OncoNano Medicine, Inc.
Sairopa B.V.
Incyte Corporation
Therorna
Artios Pharma Ltd
Tempus AI
Massive Bio, Inc.
Incyte Corporation
NiKang Therapeutics, Inc.
Nurix Therapeutics, Inc.
Regeneron Pharmaceuticals
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Pfizer
Incyte Corporation